Application 010418

Type
NDA
Sponsor
ASTRAZENECA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
005XYLOCAINELIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION1%NoNo
006XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION0.005MG/ML;1%NoNo
007XYLOCAINELIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION2%NoNo
008XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION0.005MG/ML;2%NoNo
009XYLOCAINELIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION1.5%NoNo
010XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTION0.005MG/ML;1.5%NoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N010418-005XYLOCAINELIDOCAINE HYDROCHLORIDE1%INJECTABLE / INJECTIONApproved before 1982
N010418-006XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 1982
N010418-007XYLOCAINELIDOCAINE HYDROCHLORIDE2%INJECTABLE / INJECTIONApproved before 1982
N010418-008XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 1982
N010418-009XYLOCAINELIDOCAINE HYDROCHLORIDE1.5%INJECTABLE / INJECTIONApproved before 1982
N010418-010XYLOCAINE W/ EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-009XYLOCAINE1.5%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010418-010XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1.5%INJECTABLE / INJECTIONApproved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010418-005XYLOCAINE1%INJECTABLE / INJECTIONApproved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010418-006XYLOCAINE W/ EPINEPHRINE0.005MG/ML;1%INJECTABLE / INJECTIONApproved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010418-007XYLOCAINE2%INJECTABLE / INJECTIONApproved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010418-008XYLOCAINE W/ EPINEPHRINE0.005MG/ML;2%INJECTABLE / INJECTIONApproved before 1982b8a1b40f171c…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 16 · 315 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lidocaine hydrochlorideLIDOCAINE HYDROCHLORIDEAtlantic Biologicals Corp.401ecb6c-392b-1d74-e063-6294a90a40052025-10-01Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDEHenry Schein, Inc.ee21518e-b3ed-405a-ac3b-bfe753893dba2025-09-29Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Medi-First BurnLIDOCAINE HYDROCHLORIDEUnifirst First Aid Corporation44bb5f25-1114-4bb1-8bcf-40402594abc42025-09-09WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
MediFirst BurnLIDOCAINE HYDROCHLORIDEUnifirst First Aid Corporation9fa5b348-29c2-4cd0-a945-0486bd27f5e02025-09-08WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine HydrochlorideLIDOCAINE HYDROCHLORIDEUnifirst First Aid Corporation4c2e2b91-d2f6-4e41-9a4c-ecabca9830e82025-09-08WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
HealthWise 4% Lidocaine Cream 2.7 ozLIDOCAINE HYDROCHLORIDEVeridian Healthcaref39eb3d0-e153-4f50-85b1-ad5c677d176c2025-08-28WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine HydrochlorideLIDOCAINE HYDROCHLORIDECintas First Aid & Safety96f17095-31f3-4b8a-ab22-0caaefaa74762025-08-15WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Aruba Aloe AlcoholadaLIDOCAINE HYDROCHLORIDEAruba Aloe Balm NVf56c62b0-75db-4499-858e-54e10b0e140a2025-08-07WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine HydrochlorideLIDOCAINE HYDROCHLORIDELannett Company, Inc.c3353e08-2a8c-4ace-ba89-114f7131b8de2025-08-07Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
XylocaineLIDOCAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE INJECTION, SOLUTIONHenry Schein, Inc9e8d0318-b2fe-4084-aedf-de97f61605a82025-08-07Warnings, Adverse reactionsName fallback
brand name: Xylocaine
LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDEAurobindo Pharma Limitedab461805-413a-4fb3-88a1-224e1c4230842025-07-30Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
XylocaineLIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATEProPharma Distribution386c23fd-1691-98b2-e063-6294a90ab0702025-07-18Warnings, Adverse reactionsName fallback
brand name: Xylocaine
QUALITY CHOICE Maximum Strength Lidocaine Pain Relief Roll OnLIDOCAINE HYDROCHLORIDECHAIN DRUG MARKETING ASSOCIATION7b3ff4c1-0b60-4f7a-8aa4-c84b7c7137c42025-07-11WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine HydrochlorideLIDOCAINE HYDROCHLORIDESun Pharmaceutical Industries, Inc.845b96c1-36a3-431f-8316-112ae881d9342025-07-07Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDEHenry Schein, Inc.767374af-89d1-4c19-bd8e-480699b45cf72025-06-11Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
BurnLIDOCAINE HYDROCHLORIDEJ&A Digital Inc.d4b09055-b93e-466f-9e24-cae098af6e242025-06-02WarningsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
XylocaineLIDOCAINE HYDROCHLORIDEAsclemed USA, Inc.25370b0f-0ac6-4a03-abe6-d73d651921802025-05-31Warnings, Adverse reactionsName fallback
brand name: Xylocaine
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine hydrochlorideLIDOCAINE HYDROCHLORIDEATLANTIC BIOLOGICALS CORP.75d17334-6876-42d0-8a02-82669d139e4f2025-05-12Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
Lidocaine HydrochlorideLIDOCAINE HYDROCHLORIDEHuons Co., Ltd.8ec2d256-fc4f-44f6-bee2-eef2bf3bf5802025-05-09Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE
LidocaineLIDOCAINE HYDROCHLORIDEHikma Pharmaceuticals USA Inc.5523fdfe-69fd-49a5-b51f-73e2223d49a92025-05-01Warnings, Adverse reactionsName fallback
generic name: LIDOCAINE HYDROCHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.